Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5CL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,058
Award facts
- Contract value 100% obligated
- $47,057.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $47,057.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens with a completion date of January 9, 2026. The contract, which is not set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of brand-name and generic medications, vaccines, and medical devices to federal healthcare systems, particularly supporting the Defense Health Agency and military treatment facilities worldwide. The company's competitive positioning within the DLA's pharmaceutical supply chain reflects its capability to fulfill federal medical procurement requirements across multiple therapeutic domains. This particular order for Zepbound, a diabetes medication, aligns with the company's demonstrated expertise in supplying specialty medications and critical care materials to support military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5CL5?
SPE2DR26F5CL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F5CL5 worth?
The government has obligated $47,058 on SPE2DR26F5CL5.
Is contract SPE2DR26F5CL5 an order under another contract?
Yes. SPE2DR26F5CL5 is a delivery order under SPE2DR25D7068, an indefinite delivery contract.
Was contract SPE2DR26F5CL5 competed?
The extent of competition for SPE2DR26F5CL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award